Search results
Results From The WOW.Com Content Network
The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so that physicians would prescribe a specific migraine drug to patients ...
The Anti-Kickback Statute [1] (AKS) is an American federal law prohibiting financial payments or incentives for referring patients or generating federal healthcare business. . The law, codified at 42 U.S. Code § 1320a–7b(b), [2] imposes criminal and, particularly in association with the federal False Claims Act, civil liability on those who knowingly and willfully offer, solicit, receive ...
For example, in the United States, companies providing medical services to Medicare patients were paying doctors to send patients to them, whether or not the patient needed the treatment, diagnosis, or test. [6] In 1986, the United States Congress passed the stringent Anti-Kickback Enforcement Act to prevent such schemes. [7]
Signed into law by President Ronald Reagan on November 7, 1986 The Anti-Kickback Enforcement Act of 1986 ( Pub. L. 99–634 , 100 Stat. 3523 , enacted November 7, 1986 , originally codified at 41 U.S.C. § 51 et seq., recodified at 41 U.S.C. ch. 87 ) modernized and closed the loopholes of previous statutes applying to government contractors .
A judge dismissed Pfizer Inc's challenge to a U.S. anti-kickback law that the drugmaker said prevents it from helping Medicare patients afford two drugs that treat a sometimes fatal heart ...
For premium support please call: 800-290-4726 more ways to reach us
The first qui tam case under the amended False Claims Act was filed in 1987 by an eye surgeon against an eye clinic and one of its doctors, alleging unnecessary surgeries and other procedures were being performed. [18] The case settled in 1988 for a total of $605,000. However, the law was primarily used in the beginning against defense contractors.
In 2013, the American Medical Association offered physicians training to understand the Sunshine Act. [ 3 ] A recent 2024 analysis suggests nearly 60% of experts who reviewed manuscripts for four major medical journals received at least one payment from the industry over a recent three-year period, with a total exceeding $1 billion. [ 4 ]